Bank of Baroda's $600mn NMC settlement puts UAE hospital debt controls on CFO agenda

Bank of Baroda agreed to pay $600 million to settle NMC Health litigation, putting lender due diligence back on the agenda for UAE hospital groups.

For CFOs, CEOs and COOs, the takeaway is immediate: weak treasury controls can become a board, creditor and licensing issue long before a court reaches judgment.

What was settled

Moneycontrol reported on 9 July 2026 that Bank of Baroda agreed to pay $600 million, about Rs 5,700 crore, to the joint administrators of NMC Health, NMC Healthcare and NMC Holding. The settlement covered proceedings before the Abu Dhabi Global Market Court of First Instance and the High Court of Justice of England and Wales, according to the Moneycontrol report.

"This settlement was taken after a careful assessment of the commercial considerations involved, including time, cost and the uncertainties of a prolonged litigation," Debadatta Chand, managing director and CEO of Bank of Baroda, said on 24 July 2026.

Bank of Baroda said the agreement carried no admission of liability or wrongdoing. The lender later said the one-time charge was recognised in its June 2026 quarter, reducing net profit to Rs 1,278 crore; without the charge, profit would have been Rs 5,528 crore, according to the bank's quarterly comments reported by ETBFSI.

Why UAE operators should care

NMC Health was founded in 1975, listed in London in 2012, entered the FTSE 100 in 2017 and collapsed into administration in 2020 after disclosures of hidden debt. The UK Financial Conduct Authority said in November 2023 that NMC Health reported total debt of $2.1 billion for the half year ended 30 June 2019, when the actual figure was $6.2 billion.

For healthcare CFOs, the case turns bank covenants, facility use, related-party exposure and receivables financing into evidence that lenders, administrators and courts can test. For CEOs, it links debt governance to M&A pricing and creditor access. For COOs, it makes finance controls part of service continuity because a liquidity shock can reach payroll, supplier terms and patient operations.

• $600 million was the agreed settlement amount.
• 23 March 2026 was the reported start date of the ADGM trial.
• Rs 1,278 crore was Bank of Baroda's reported June 2026 quarter profit after the charge.
• $6.2 billion was the debt figure the FCA cited for NMC Health as of 30 June 2019.

Regulatory context

The court process sat in Abu Dhabi Global Market, but healthcare operators should read it beside the UAE's health regulatory structure. In Dubai, the Dubai Health Authority (DHA) supervises licensed private facilities. In Abu Dhabi and Al Ain, the Department of Health - Abu Dhabi (DOH) regulates providers. In the Northern Emirates, the Ministry of Health and Prevention (MOHAP) is the relevant authority.

DHA, DOH and MOHAP do not regulate bank lending. They do control facility licensing, ownership approvals, clinical governance and some reporting obligations tied to continuity of care. A healthcare group with weak treasury controls can create a regulatory problem if a creditor dispute threatens services, staffing or the transfer of medical records.

The next number to watch in 2026 is the cost of debt for UAE healthcare borrowers with complex ownership, receivables financing or group guarantees. Operators seeking expansion loans should expect more lender questions on beneficial ownership, auditor independence, receivables quality and board oversight after the NMC Health settlement.